"Trump Media & Technology (NASDAQ: DJT) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, and PRSO Emerge"

Getting your Trinity Audio player ready...

Trump Media & Technology Group (NASDAQ: DJT), the company behind Truth Social, witnessed a sharp surge on Election Day, with shares climbing as traders bet that a second Trump presidency could reignite business prospects. The stock, often regarded as a proxy for the former president’s White House chances, has seen heavy retail interest, especially on platforms like WallStreetBets, where it topped discussions, opening the way to small cap stocks some mentioned herein.

Trump Media & Technology (NASDAQ: DJT), the operator of Truth Social, surged on Election Day, as traders speculated that a second Trump presidency could boost its business prospects. Seen as a proxy for Trump’s potential return to the White House. Despite a 33% drop last week, DJT rose 12% on Monday and gained 16.8% today in early trading. “We are trading this like GameStop (NYSE: GME) on steroids right now,” said Jay Woods, chief capital strategist at Freedom Capital Markets, on CNBC Monday. Retail interest remains high, with DJT topping discussions on WallStreetBets, though analysts caution that its long-term metrics lack fundamental support.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) is developing CardiolRx™ positioned as a treatment for myocarditis, a serious inflammation of the heart muscle often linked to viral infections, among other health conditions. Myocarditis can lead to severe complications, including heart failure, arrhythmias, and even sudden cardiac death to people of all ages. By leveraging its expertise in developing anti-inflammatory therapies, Cardiol Therapeutics seeks to improve patient outcomes at risk of heart-related complications due to inflammation.

Avalon GloboCare (NASDAQ: ALBT) has appointed Dr. Charles Cavo to its Advisory Board to advance the marketing of KetoAir™, a handheld breathalyzer for ketosis monitoring. With expertise in obesity and metabolic health, Dr. Cavo, co-founder of Pounds Transformation, will support strategic partnerships and guide KetoAir™’s business plan. Designed for real-time metabolic insights, KetoAir™ aids weight management and conditions like diabetes by measuring adherence to ketogenic diets, aligning with the growing relevance of GLP-1-based dietary approaches.

ZyVersa Therapeutics (Nasdaq: ZVSA) has highlighted new data showing that inhibiting the NLRP3 inflammasome can protect pancreatic islet beta cells, potentially slowing the progression from obesity to insulin resistance and type 2 diabetes. Published in the International Journal of Nanomedicine, the study demonstrated that inflammasome inhibition preserved beta cell function and improved metabolic health in an obesity mouse model. These findings support ZyVersa’s development of its Inflammasome ASC Inhibitor IC 100, intended as an add-on to incretin therapy for treating obesity-related metabolic conditions.

Peraso Inc. (NASDAQ: PRSO), a leader in wireless technology, announced agreements for the immediate exercise of certain Series B warrants, allowing the purchase of 2,246,030 shares of common stock at a reduced price of $1.30 per share. This exercise is expected to generate $2.9 million in gross proceeds, and a new strong trading market at a range reflecting the $1.30 warrant exercise price is emerging. Ladenburg Thalmann & Co. Inc. serving as the exclusive placement agent for this offering.

With continued strong retail support and ongoing market momentum, Trump Media & Technology (NASDAQ: DJT) remains a focal point for traders eyeing political trends, though experts warn about the risks tied to its fundamentals.